Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
362 studies found for:    Osteosarcoma
Show Display Options
Rank Status Study
21 Completed Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Gemcitabine plus rapamycin
22 Completed
Has Results
Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Cisplatin;   Drug: Doxorubicin;   Drug: Methotrexate
23 Unknown  Pilot Study of Curcumin Formulation and Ashwagandha Extract in Advanced Osteosarcoma
Condition: Osteosarcoma
Interventions: Dietary Supplement: Curcumin powder;   Dietary Supplement: Ashwagandha extract
24 Terminated Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
Conditions: Osteosarcoma;   Paget's Disease
Intervention:
25 Completed Inhalation SLIT Cisplatin for the Treatment of Osteosarcoma Metastatic to the Lung
Condition: Osteosarcoma
Intervention: Drug: SLIT Cisplatin
26 Terminated
Has Results
High Dose Methotrexate With Leucovorin Rescue With or Without Glucarpidase in Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: glucarpidase;   Drug: leucovorin
27 Recruiting Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma Therapy
Conditions: Osteosarcoma;   Nephrotoxicity;   Ototoxicity
Interventions: Drug: Pantoprazole;   Drug: High-dose methotrexate infusion duration
28 Unknown  Evaluation of Zoledronic Acid as a Single Agent or as an Adjuvant to Chemotherapy in High Grade Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Zoledronic acid;   Drug: Standard chemotherapy
29 Completed Development of Indices Predicting Response to Pre-operative Chemotherapy in Osteosarcoma Patients
Condition: Osteosarcoma
Intervention:
30 Completed Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma;   Recurrent Osteosarcoma
Intervention: Other: laboratory biomarker analysis
31 Recruiting Outpatient Administration of High Dose Methotrexate (HD MTX) in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: High Dose Methotrexate
32 Active, not recruiting A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
Condition: Osteosarcoma
Interventions: Drug: Mifamurtide;   Drug: Ifosfamide
33 Not yet recruiting Therapy Trial to Determine the Safety and Efficacy of Heavy Ion Radiotherapy in Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Radiation: heavy ion radiotherapy (C12)
34 Unknown  A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo
35 Active, not recruiting Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
Condition: Pulmonary Relapse of Osteosarcoma
Intervention: Drug: Inhaled Lipid Cisplatin (ILC)
36 Recruiting ABCB1/P-glycoprotein Expression as Biologic Stratification Factor for Patients With Non Metastatic Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Mifamurtide arm;   Other: 3 drugs arm
37 Recruiting Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
Conditions: Solid Tumor;   Osteosarcoma
Intervention: Drug: Sirolimus combined with CP, MT and ZA
38 Recruiting Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI
Conditions: Bone Cancer;   Chondrosarcoma;   Ewing's Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Bone Necrosis;   Bone Sarcoma;   Osteomyelitis
Interventions: Drug: Feraheme;   Procedure: MR Scan
39 Suspended Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma
Conditions: Desmoplastic Small Round Cell Tumor;   Disseminated Neuroblastoma;   Metastatic Osteosarcoma;   Recurrent Neuroblastoma;   Recurrent Osteosarcoma
Interventions: Biological: IL-2;   Biological: GD2Bi-aATC;   Biological: GM-CSF;   Other: laboratory evaluations of immune responses
40 Recruiting Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas
Conditions: Adult Liposarcoma;   Metastatic Liposarcoma;   Metastatic Osteosarcoma;   Recurrent Adult Soft Tissue Sarcoma;   Recurrent Liposarcoma;   Recurrent Osteosarcoma;   Stage IV Adult Soft Tissue Sarcoma
Interventions: Drug: Pazopanib Hydrochloride;   Drug: Oral Topotecan Hydrochloride;   Other: Laboratory Biomarker Analysis

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years